JANUARY 17, 2022 by University of Sussex Figure 1. Experimental pipeline. sEVs from GB patients and healthy volunteers’ blood samples were isolated through UC. The proteomic content of the sEVs were deciphered using mass spectrometry. Figure was created using BioRender.com. Credit: DOI: 10.3390/biomedicines10010125 Researchers at the University of Sussex are one step further to developing a...
UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER HOUSTON ― A blood test, combined with a risk model based on an individual’s history, more accurately determines who is likely to benefit from lung cancer screening than the current U.S. recommendation, according to a study published today in the Journal of Clinical Oncology led by researchers...
by University of Oxford Credit: Pixabay/CC0 Public Domain A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms. A University of Oxford study published in Clinical Cancer Research, a journal of the American Association for Cancer Research, outlines a new type...
by Massachusetts General Hospital Lung CA seen on CXR. Credit: James Heilman, MD/Wikipedia Lung cancer, the leading cause of cancer death, is usually diagnosed at a late stage when the survival rate is extremely low. Early-stage lung cancer is mostly asymptomatic, and low-dose spiral CT imaging, the current method for detecting early lung cancer lesions, isn’t...
Nilima Marshall, PA Science Reporter Thu, 24 June 2021 A simple blood test that can detect more than 50 types of cancer before any clinical signs or symptoms of the disease is accurate enough to be rolled out as a multi-cancer screening test, according to scientists. The test, which is also being piloted by NHS...
by Osaka University Thrombospondin 2 is a new diagnostic and prognostic serum biomarker in NAFLD. Credit: Osaka University Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide and can progress to liver cirrhosis, liver failure, or cancer. Currently, nonalcoholic steatohepatitis (NASH) diagnosis requires an invasive liver biopsy which can lead to procedural complications....
by King’s College London Credit: CC0 Public Domain A new study of over 3000 people led by King’s College London in collaboration with Lund University, has shown for the first time that a single biomarker can accurately indicate the presence of underlying neurodegeneration in people with cognitive issues. Levels of a protein called neurofilament light chain...
One challenge as society reopens is identifying who has been vaccinated for SARS-CoV-2, the virus that causes COVID-19. The new COVID-19 antibody test is similar to one used at home to determine blood type, where the user pricks a finger and places a drop of blood on a card. A fusion protein the research team developed that’s...
by Indiana University School of Medicine Alexander B. Niculescu, MD, PhD. Credit: IU School of Medicine Worldwide, 1 in 4 people will suffer from a depressive episode in their lifetime. While current diagnosis and treatment approaches are largely trial and error, a breakthrough study by Indiana University School of Medicine researchers sheds new light on the biological basis...
by Max Planck Society Blood panels are as individual as fingerprints. Researchers from the attoworld team at LMU and MPQ have now investigated how stable this so-called molecular fingerprint of the blood is over time. Credit: Max Planck Institute of Quantum Optics The molecular composition of the blood provides information regarding one’s state of health, and...
